Citius Pharmaceuticals, Inc. (CTXR) — Stock Valuation & Research

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both…

CTXR key statistics

Price$0.52
Market cap$14.28M
SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
52-week range0.3699-1.54
Beta1.04

Explore CTXR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.